These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29927744)

  • 41. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Usefulness and limitations of thyroglobulin determination in thyroid neoplasms].
    Dussault J
    Union Med Can; 1983 Dec; 112(12):1119-20, 1123. PubMed ID: 6665951
    [No Abstract]   [Full Text] [Related]  

  • 43. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.
    Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA
    Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Advances in thyroglobulin assays and their impact on the management of differentiated thyroid cancers].
    d'Herbomez M; Lion G; Béron A; Wémeau JL; DoCao C
    Ann Biol Clin (Paris); 2016; 74(1):21-7. PubMed ID: 26711165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Usefulness of blood thyroglobulin determination in patients with thyroid cancer].
    Ikekubo K; Hamasaki T; Yamada A; Bito S; Tochio H; Saiki Y; Ito H; Morimoto Y; Akamizu T; Sawada K
    Kaku Igaku; 1983 Apr; 20(3):313-9. PubMed ID: 6632358
    [No Abstract]   [Full Text] [Related]  

  • 46. [Determination of serum thyroglobulin in differentiated thyroid cancer. A review and 3 cases].
    Feldt-Rasmussen U; Hansen HS; Rasmusson B
    Ugeskr Laeger; 1983 Apr; 145(15):1132-6. PubMed ID: 6879741
    [No Abstract]   [Full Text] [Related]  

  • 47. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
    Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High serum thyroglobulin levels. Diagnostic indicators in patients with metastases from unknown primary sites.
    Panza N; Lombardi G; De Rosa M; Pacilio G; Lapenta L; Salvatore M
    Cancer; 1987 Nov; 60(9):2233-6. PubMed ID: 3440233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of three immunoassay kits for serum thyroglobulin in patients with thyroid cancer.
    Dai J; Dent W; Atkinson JW; Cox JG; Dembinski TC
    Clin Biochem; 1996 Oct; 29(5):461-5. PubMed ID: 8884068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum thyroglobulin measurements: clinical utility and technical limitations in the management of patients with differentiated thyroid carcinomas.
    Spencer CA
    Endocr Pract; 2000; 6(6):481-4. PubMed ID: 11155225
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum thyroglobulin in differentiated thyroid carcinoma.
    Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
    Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serum thyroglobulin in the follow-up of patients treated for differentiated carcinoma of the thyroid. Evaluation of factors determining its effectiveness].
    García Solís D; Rodríguez Rodríguez JR; Acosta D; Astorga R
    Med Clin (Barc); 1986 May; 86(18):748-52. PubMed ID: 3736171
    [No Abstract]   [Full Text] [Related]  

  • 54. Warthin's tumour mimicking nodal involvement by thyroid cancer and unexplained elevation of serum thyroglobulin.
    Loo SW; Lu SJ; Geropantas K; Martin C; Roques TW
    Hell J Nucl Med; 2011; 14(2):184-5. PubMed ID: 21761028
    [No Abstract]   [Full Text] [Related]  

  • 55. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
    Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
    Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
    Li D; Butt A; Clarke S; Swaminathana R
    Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prognostic value of thyroglobulin levels for survival in patients with differentiated carcinoma of the thyroid gland].
    Nĕmec J; Bílek R; Zamrazil V; Chytrý P; Vlcek P
    Cas Lek Cesk; 1997 Dec; 136(23):23-4. PubMed ID: 9476372
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
    Giovanella L; Imperiali M; Verburg FA; Ceriani L
    Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.
    Smallridge RC; Meek SE; Morgan MA; Gates GS; Fox TP; Grebe S; Fatourechi V
    J Clin Endocrinol Metab; 2007 Jan; 92(1):82-7. PubMed ID: 17077133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical evaluation of serum thyroglobulin measurement using a commercial kit in the diagnosis of recurrent thyroid cancer.
    Tokmakjian SD; Haines DS; Driedger AA
    Clin Biochem; 1989 Oct; 22(5):395-9. PubMed ID: 2805343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.